The increasing volume of research by the medical community often leads to increasing numbers of contradictory findings and
conclusions. Although the differences observed may represent true differences, the results also may differ because of sampling
variability as all studies are performed on a limited number of specimens or patients. When planning a study reporting differences
among groups of patients or describing some variable in a single group, sample size should be considered because it allows
the researcher to control for the risk of reporting a false-negative finding (Type II error) or to estimate the precision
his or her experiment will yield. Equally important, readers of medical journals should understand sample size because such
understanding is essential to interpret the relevance of a finding with regard to their own patients. At the time of planning,
the investigator must establish (1) a justifiable level of statistical significance, (2) the chances of detecting a difference
of given magnitude between the groups compared, ie, the power, (3) this targeted difference (ie, effect size), and (4) the
variability of the data (for quantitative data). We believe correct planning of experiments is an ethical issue of concern
to the entire community.
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest,
patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.